In 1956, the Virginia Mason Research Center, now known as Benaroya Research Institute at Virginia Mason (BRI), located in Seattle, is focused on molecular and cellular biology of the human immune system and on genetics of human diseases.

BRI has a clinical research program that supports more than 150 studies each year, primarily Phase II-III medication and device trials, in 25 different subspecialty areas.